AKKA: Forward EPS lowered by 30-50%, new TP of € 45 Argenx: Efgartigimod on track for gMG mid20, cash € 1.3bn Bekaert: Weak 1Q top line but cost control saves bottom line Boskalis: 1Q20 trading update CFE: DEME concludes the sale of its Merkur stake Euronext: Covid-19 trading supports strong CSS beat EVS: OK end April order book but no guidance for FY20 Immobel: Completes sale of 800k treasury shares Kiadis: NK-cell capabilities presented at conferences Montea: Encouraging 1Q20 update Picano...
AB InBev: Clearance for sale of Australian business Ackermans: Cuts FY19 dividend CFE: Cuts dividend and FY20 outlook IO&W: Covid-19 update KBC Ancora: Dividend in June based on KBC Group interim € 1 ps Proximus: Investment spree starts but returns are distant
Aedifica: Controls 95.5% of the Hoivatilat shares CFE: Successful installation of SeaMade foundations Fugro: Unfavourable outcome Southern Star arbitrage Greenyard: Sells Portugal Logistics through MBO Mithra: New license agreement for Tibelia in Italy Oxurion: THR-687 reveals positive phase I outcome Sequana Medical: 1st patient enrolled in the 2nd FIH heart DSR study WDP: Increase TP to € 24 ps (from € 20)
bpost: Government extends press concessions CFE: Sale of Merkur Offshore wind farm Colruyt: Strong calendar effect, guidance reiterated Oxurion: pKal pathway – friend or foe? Merck will tell? UCB: Update on Roza in ITP at ASH. Positive phase II data
Celyad: New OptimAb CYAD-01 product: 1st patient dosed CFE: Feedback analyst meeting and update post 1H19 CP Invest: Succeeds in 109th investment – 7th in NL Oxurion: THR-687 integrin drug: phase I safety data YE19 Telenet: Soft launch of FWA-service, Tadaam
Despite showing itself capable of weathering the storm of a slow dredging market relatively well, a flattish 2019 outlook and a postponed Dredging market recovery combined with increased macro uncertainty has continued to put pressure on the share. With a massive extended order book of € 6.5bn and two new, ultra-efficient flagships just beyond the horizon to exploit it, as well as a market leading position in a rapidly expanding offshore wind market, CFE in our view is setting up for strong EB...
Adyen: PSD2-enabled Open Banking to support growth Bois Sauvage: Insects and Chocolates Boskalis: Survey acquisition of Horizon Group CFE: Grouping of Offshore activities Cofinimmo: Quartz development fully let Deceuninck: FY18 REBITDA +6.4%, slightly better than expected EVS: Expected acceleration in 2H18 after a weak 1H18 Fugro: Preview FY18 results Gimv: 3Q Update, NAV at € 49.3 p.s. GrandVision: Expanding its Iberian footprint Heijmans: Strong 2H18 results Kinepolis: Landmark Cinemas Canad...
ASR: Acquires Loyalis from APG Biocartis: Genomic Health collab expands into urology bpost: Throwing in the towel Celyad: AML: update on CYAD-01 at ASH CFE: SeaMade € 500m EPCI offshore wind contract Cofinimmo: Company note: Investment pipeline shifts up a gear GBL: Passing of Honorary Chairman, Albert Frère
Aedifica: FY17-18 results preview Agfa: Intention to acquire the prepress business of Ipagsa CFE: Feedback analyst meeting CP Invest: 1H18 results preview ING: Fine of € 775m draws a line on another chapter PostNL: Wins appeal case on Significant Market Power Thrombogenics: Looking towards the future with Oxurion
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.